Patent Yard Sign in
Canadian application, no grantCanada

Compositions and methods for use in recombinational cloning of nucleic acids

CA 2363924 A1 · Owner: Brasch, Michael A. · Inventors: Temple, Gary F.; Cheo, David; Hartley, James L.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention relates generally to compositions and methods for use in recombinational cloning of nucleic acid molecules. In particular the , invention relates to nucleic acid molecules encoding one or more recombination sites or portions thereof, to nucleic acid molecules comprising one or more of these recombination site nucleotide sequences and optionally comprising one or more additional physical or functional nucleotide sequences. The invention also relates to vectors comprising the nucleic acid molecules of the invention, to host cells comprising the vectors or nucleic acid molecules of the invention, to methods of producing polypeptides using the nucleic acid …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed March 2, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 2, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 2, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 2, 2000
GrantedNo grant recorded
Term endedMarch 2, 2020
Patent numberCA 2363924 A1
Classification (IPC)C12N15/12 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedMarch 2, 2000Term endedMarch 2, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.